HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 14 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
PAPOLA
poly(A) polymerase alpha
Chromosome 14 · 14q32.2
NCBI Gene: 10914Ensembl: ENSG00000090060.19HGNC: HGNC:14981UniProt: A0A0C4DGK1
65PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedHub Gene
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathwaypoly(A) RNA polymerase activitynucleoplasmmRNA 3'-end processingneurodegenerative diseaseAlzheimer diseaseParkinson diseaselysosomal storage disease
✦AI Summary

PAPOLA (poly(A) polymerase alpha) is a nuclear polymerase that synthesizes the 3'-poly(A) tail on mRNA molecules, a critical step in mRNA maturation and stability 1. Beyond tail synthesis, PAPOLA also participates in the endonucleolytic cleavage reaction required at polyadenylation sites, acquiring specificity through interactions with cleavage and polyadenylation specificity factor (CPSF) [UniProt]. The enzyme possesses poly(A) RNA polymerase activity and binds ATP, magnesium, and manganese ions, enabling catalytic function in the nucleus and cytoplasm. PAPOLA functions redundantly with related tailing enzymes TENT2 and PAPOLG to adenylate unadenylated RNAs arising from premature transcription termination 1. These adenylated transcripts are subsequently targeted for degradation through the nuclear Poly(A) tail eXosome Targeting (PAXT) pathway or exported for cytoplasmic degradation, preventing accumulation of aberrant transcripts that would otherwise impair translation and cell viability 1. Thus, PAPOLA serves as a safeguard mechanism protecting cells from products of pervasive transcription, playing an essential role in post-transcriptional quality control.

Sources cited
1
PAPOLA adenylates unadenylated RNAs and these adenylated transcripts are targeted for degradation via PAXT or cytoplasmic exosome, preventing translation impairment and cell death
PMID: 39617768
⚠Limited data available — This gene has 1 indexed publication. Summary and analysis may be incomplete.
Disease Associationsⓘ20
neurodegenerative diseaseOpen Targets
0.46Moderate
Alzheimer diseaseOpen Targets
0.43Moderate
Parkinson diseaseOpen Targets
0.42Moderate
lysosomal storage diseaseOpen Targets
0.42Moderate
multiple sclerosisOpen Targets
0.42Moderate
dengue diseaseOpen Targets
0.37Weak
neuroinflammatory disorderOpen Targets
0.35Weak
dental cariesOpen Targets
0.11Weak
ovarian neoplasmOpen Targets
0.09Suggestive
pulmonary tuberculosisOpen Targets
0.08Suggestive
breast cancerOpen Targets
0.08Suggestive
connective tissue diseaseOpen Targets
0.07Suggestive
Sjogren syndromeOpen Targets
0.07Suggestive
prostate cancerOpen Targets
0.07Suggestive
alcohol drinkingOpen Targets
0.06Suggestive
malignant renal pelvis neoplasmOpen Targets
0.06Suggestive
digestive system neoplasmOpen Targets
0.06Suggestive
hypoparathyroidism, familial isolated, 2Open Targets
0.04Suggestive
celiac diseaseOpen Targets
0.04Suggestive
intestinal hypomagnesemia 1Open Targets
0.04Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
SYMPKProtein interaction100%ZCCHC7Protein interaction100%MTREXProtein interaction100%PABPN1Protein interaction99%SNRNP70Protein interaction99%CPSF2Protein interaction99%
Tissue Expression6 tissues
Bone Marrow
100%
Heart
93%
Ovary
78%
Brain
73%
Liver
64%
Lung
61%
Gene Interaction Network
Click a node to explore
PAPOLASYMPKZCCHC7MTREXPABPN1SNRNP70CPSF2
PROTEIN STRUCTURE
Preparing viewer…
PDB8R8R · 2.79 Å · EM
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
0.21Highly Constrained
pLIⓘ
1.00Intolerant
Observed/Expected LoF0.08 [0.04–0.21]
RankingsWhere PAPOLA stands among ~20K protein-coding genes
  • #7,193of 20,598
    Most Researched65
  • #530of 17,882
    Most Constrained (LOEUF)0.21 · top 5%
Genes detectedPAPOLA
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Psychotherapies for Generalized Anxiety Disorder in Adults: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
PMID: 37851421
JAMA Psychiatry · 2024
1.00
2
Cognitive Behavior Therapy for Mental Disorders in Adults: A Unified Series of Meta-Analyses.
PMID: 40238104
JAMA Psychiatry · 2025
0.90
3
[Not Available].
PMID: 39012191
Z Psychosom Med Psychother · 2024
0.80
4
EMDR
PMID: 38173121
Psychol Med · 2024
0.70
5
Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials.
PMID: 28931508
BMJ · 2017
0.60